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Abstract
Long-term care insurance (LTCI) covers are rather recent products, in
the framework of health insurance. It follows that specific biometric
data are scanty, and pricing problems then arise because of difficulties
in the choice of appropriate technical bases. Different benefit struc-
tures imply different sensitivity degrees with respect to changes in bio-
metric assumptions. Hence, an accurate sensitivity analysis can help
in designing LTCI products, and, in particular, in comparing stand-
alone products to combined products, i.e. packages including LTCI
benefits and other lifetime-related benefits.
Keywords: Long-term care, Biometric functions, Multistate models,
Mortality laws, Mortality of disabled people.
1 Introduction
Long-term care insurance (LTCI) products deserve, in the framework of
health insurance, special attention. Actually, on the one hand LTCI pro-
vides benefits of remarkable interest in the current demographic and social
scenario, and, on the other, LTCI covers are “difficult” products.
We note in particular the following aspects:
• in many countries, shares of elderly population are rapidly growing
because of increasing life expectancy and low fertility rates;
• household sizes are progressively reducing, and this implies lack of as-
sistance and care services provided to old members of the family inside
the family itself;
• LTCI products are rather recent, and consequently senescent disability
data are scanty; pricing (and reserving) problems then arise because of
difficulties in the choice of appropriate technical bases;
• high premiums (in particular due to a significant safety loading) charged
to policyholders constitute an obstacle to the diffusion of these products
(especially stand-alone LTC covers which only provide “protection”).
While managing a portfolio of policies in the area of the insurances of
the person, the insurer takes various risks, in particular biometric risks, i.e.
related to mortality, disability, etc. For each risk, various components can
be recognized, and, in particular, the risk of random fluctuations (of mor-
tality, disability, etc.) around the relevant expected values, and the risk of
systematic deviations from the expected values. As is well known, the former
is diversifiable via pooling, whereas the latter is undiversifiable via pooling,
and its impact is larger when the portfolio size is larger.
The risk of systematic deviations is frequently originated by uncertainty
in the technical bases (i.e. assumptions regarding mortality, disability, etc.).
This paper focusses on the uncertainty in the technical bases which must
be adopted when pricing and reserving for LTCI policies. A sensitivity anal-
ysis will be performed, in order to assess the change in expected present value
of benefits provided by LTCI products when changing in particular:
• the assumptions about senescent disability, in terms of probability of
entering the LTC state(s);
• the age-pattern of mortality of people in LTC state(s).
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The sensitivity analysis will be performed starting from the biometric as-
sumptions proposed by Rickayzen and Walsh (2002) and Rickayzen (2007).
Both LTC stand-alone covers and LTC combined products will be addressed,
and the advantages provided by packaging LTC benefits together with lifetime-
related benefits (i.e. conventional life annuities and death benefits) will be
checked.
The remainder of the paper is organized as follows. In Sect. 2 we describe
the basic long-term care insurance products, whereas Sect. 3 focusses on a
simple actuarial model for premium calculation. Formulae for premiums and
related numerical examples are provided in Sect. 4. The sensitivity analysis
is the object of Sect. 5, which constitutes the core of the paper. Some final
remarks in Sect. 6 conclude the paper.1 2
2 Long-term care insurance products
Long-term care insurance (LTCI) provides the insured with financial support,
while he/she needs nursing and/or medical care because of chronic (or long-
lasting) conditions or ailments.
Several types of benefits can be provided (in particular: fixed-amount
annuities, care expense reimbursement). The benefit trigger is usually given
either by claiming for nursing and/or medical assistance (together with a san-
itary ascertainment), or by assessment of the individual disability, according
to some predefined metrics (e.g. the ADL scale, or the IADL scale; see, for
example, Pitacco (2014) and references therein).
2.1 LTCI products: a classification
Long-term care insurance products can be classified as follows:
• products which pay out benefits with a predefined amount (usually, a
lifelong annuity benefit); in particular
– a fixed-amount benefit;
– a degree-related (or graded) benefit, i.e. a benefit whose amount is
graded according to the degree of disability, that is, the severity
1 Part of the contents of this paper was presented at the CEPAR Long Term Care and
Longevity Insurance Workshop (hosted by CEPAR and PwC), Sydney, 10th December
2014.
2 The author thanks Alice Petronio (student of the Master course in Statistics and Ac-
tuarial Sciences at the University of Trieste) for performing all the numerical calculations.
Possible errors are the author’s responsibility.
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of the disability itself (for example, assessed according to an ADL
or IADL scale);
• products which provide reimbursement (usually partial) of nursery and
medical expenses, i.e. expense-related benefits;
• care service benefits (for example, provided by the Continuing Care
Retirement Communities, briefly CCRCs; see Pitacco (2014) and ref-
erences therein).
In what follows we only address LTCI products which provide predefined
amount benefits.
2.2 Fixed-amount and degree-related benefits
A classification of LTCI products which pay out benefits with a predefined
amount is proposed in Fig. 2.1.
 
 
 
 
 
 LTC Insurance 
 
predefined benefits 
Immediate care plans 
("point-of-need" plans) Pre-funded plans 
Care annuities 
Stand alone 
 
Combined 
products 
LTC rider to a 
whole-life assurance 
 
Enhanced pension 
LTC  +  lifetime- 
related benefits 
 
IP  +  LTC 
 
Life care pensions 
 
Figure 2.1: A classification of LTCI products providing predefined benefits
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Immediate care plans, or care annuities, relate to individuals already af-
fected by severe disability (that is, in “point of need”), and then consist of:
• the payment of a single premium;
• an immediate life annuity, whose annual benefit may be graded accord-
ing to the disability severity.
Hence, care annuities are aimed at seriously impaired individuals, in partic-
ular persons who have already started to incur long-term care costs. The
premium calculation is based on assumptions of short life expectancy. How-
ever, the insurer may limit the individual longevity risk by offering a limited
term annuity, namely a temporary life annuity.
Pre-funded plans consist of:
• the accumulation phase, during which periodic premiums are paid; the
accumulation can however degenerate in a single premium;
• the payout period, during which LTC benefits (usually consisting of a
life annuity) are paid in the case of LTC need.
Several products belong to the class of pre-funded plans. A stand-alone
LTC cover provides an annuity benefit, possibly graded according to an ADL
or IADL score. This cover can be financed by a single premium, by temporary
periodic premiums, or lifelong periodic premiums. Of course, premiums are
waived in the case of an LTC claim. This insurance product only provides a
“risk cover”, as there is, of course, no certainty in future LTC need and the
consequent payment of benefits.
A number of combined products have been designed, mainly aiming at
reducing the relative weight of the risk component by introducing a “saving”
component, or by adding the LTC benefits to an insurance product with a
significant saving component. Some examples follow.
LTC benefits can be added as a rider to a whole-life assurance policy.
For example, a monthly benefit of, say, 2% of the sum assured is paid in
the case of an LTC claim, for 50 months at most. The death benefit is
consequently reduced, and disappears if all the 50 monthly benefits are paid.
Thus, the (temporary) LTC annuity benefit consists in an acceleration of
the death benefit. The LTC cover can be complemented by an additional
deferred LTC annuity (financed by an appropriate premium increase) which
will start immediately after the possible exhaustion of the sum assured (that
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is, if the LTC claim lasts for more than 50 months) and will terminate at the
insured’s death.
An insurance package can include LTC benefits combined with lifetime-
related benefits, i.e. benefits only depending on insured’s survival and death.
For example, the following benefits can be packaged:
1. a lifelong LTC annuity (from the LTC claim on);
2. a deferred life annuity (e.g. from age 80), while the insured is not in
LTC disability state;
3. a lump sum benefit on death, which can alternatively be given by:
(a) a fixed amount, stated in the policy;
(b) the difference (if positive) between a stated amount and the amount
paid as benefit 1 and/or benefit 2.
Life care pensions (also called life care annuities) are life annuity products
in which the LTC benefit is defined in terms of an uplift with respect to the
basic pension b. In particular, the enhanced pension is a particular life care
pension in which the uplift is financed by a reduction (with respect to the
basic pension b) of the benefit paid while the policyholder is healthy. Thus,
the reduced benefit b′ is paid out as long as the retiree is healthy, while
the uplifted benefit b′′ will be paid in the case of an LTC claim (of course,
b′ < b < b′′).
Finally, a lifelong disability cover can include:
• an income protection cover (briefly, IP; see, for example, Pitacco (2014)
and references therein) during the working period, that is, during the
accumulation period related to LTC benefits;
• an LTC cover during the retirement period.
3 The model
In this Section we first describe some multistate models which can be adopted
to represent “states” and “transitions” related to a LTCI cover. We then intro-
duce the biometric functions which are needed to assign a stochastic structure
to the multistate model chosen for the following calculations. Actuarial val-
ues (i.e. expected present values) are then defined, and finally technical bases
are addressed.
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3.1 Multistate models
The following states are considered in Figs. 3.1 and 3.2:
a = active = healthy;
i′ = in low-severity LTC state;
i′′ = in high-severity LTC state;
i = invalid = in LTC state;
d = died.
In Fig. 3.1(a) the possibility of recovery (transitions i′ → a and i′′ → a) and
improvement (transition i′′ → i′) is allowed for. A simplified four-state model
is represented by Fig. 3.1(b), which disregards the possibility of recovery and
improvement. Disregarding these possibilities leads to simpler calculations,
and is justified by the very low probabilities of recovery and improvement
(given the usually chronic character of the senescent disability).
 
a i' 
d 
i'' 
 
a i' 
d 
i'' 
(a) (b)
Figure 3.1: Four-state models
Just one disability state (that is, i) is conversely considered by multistate
models shown in Fig. 3.2. The simplest model, i.e. the one represented in
Fig. 3.2(b), will be adopted in what follows.
For a more detailed presentation of multistate models for LTCI, the reader
can refer to Pitacco (2014), and Haberman and Pitacco (1999) where a time-
continuous context is considered.
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Figure 3.2: Three-state models
3.2 Biometric functions
We refer to three-state model shown in Fig. 3.2(b). We define, for a healthy
individual age x, the following one-year probabilities:
paax = probability of being healthy at age x+ 1;
paix = probability of being invalid at age x+ 1;
qaax = probability of dying before age x+ 1 from state a;
qaix = probability of dying before age x+ 1 from state i;
qax = probability of dying before age x+ 1;
wx = probability of becoming invalid (disablement) before age x+ 1.
For an invalid individual (i.e. an individual in state LTC) age x, we consider
the following one-year probabilities:
pix = probability of being alive (and invalid) at age x+ 1;
qix = probability of dying before age x+ 1.
The following relations obviously hold:
qax = q
aa
x + q
ai
x (3.1)
paax = 1− qaax − wx (3.2)
pix = 1− qix (3.3)
wx = p
ai
x + q
ai
x (3.4)
The (usual) approximation
qaix = wx
qix
2
(3.5)
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have been assumed; in its turn, Eq. (3.5) implies:
paix = wx
(
1− q
i
x
2
)
(3.6)
From the one-year probabilities, the following multi-year probabilities can
be derived:
kp
aa
y =
k−1∏
h=0
paay+h (3.7)
kp
i
y =
k−1∏
h=0
piy+h (3.8)
kp
ai
y =
k∑
h=1
[
k−hpaay p
ai
y+k−h h−1p
i
y+k−h+1
]
(3.9)
3.3 Actuarial values
Let v denote the annual discount factor. We define the following actuarial
values (i.e. expected present values). The usual actuarial notation is adopted.
aaix =
+∞∑
j=1
j−1paax p
ai
x+j−1 v
j a¨ix+j (3.10)
a¨ix+j =
+∞∑
h=j
vh−j h−jpix+j (3.11)
a¨ix+j:se =
j+s−1∑
h=j
vh−j h−jpix+j (3.12)
a¨aax =
+∞∑
j=0
vj jp
aa
x (3.13)
a¨aax:re =
r−1∑
j=0
vj jp
aa
x (3.14)
n|a¨aax =
+∞∑
j=n
vj jp
aa
x (3.15)
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3.4 Technical bases
We adopt the following assumptions:
qaax is given by the first Heligman-Pollard law;
wx is expressed by a specific parametric law;
qix = q
aa
x + extra-mortality, that is, an additive extra-mortality model
is assumed.
The first Heligman-Pollard law is given by:
qaax
1− qaax
= a(x+b)
c
+ d e−e (lnx−ln f)
2
+ g hx (3.16)
The parameters have been assigned the numerical values given in Table
3.1. Some corresponding markers are shown in Table 3.2, in particular:
• the (remaining) expected lifetime, ◦ex, at various ages;
• the Lexis point, i.e. the (old) age with the maximum probability of
death for a newborn;
• the one-year probability of death, qx, at various ages.
Table 3.1: The first Heligman-Pollard law; parameters
a b c d e f g h
0.00054 0.01700 0.10100 0.00014 10.72 18.67 2.00532E−06 1.13025
Table 3.2: The first Heligman-Pollard law; some markers
◦
e0
◦
e40
◦
e65 Lexis q0 q40 q80
85.128 46.133 22.350 90 0.00682 0.00029 0.03475
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The assumption by Rickayzen and Walsh (2002) has been adopted for the
one-year probability of disablement, that is:
wx =

A+
D − A
1 +BC−x
for females
(
A+
D − A
1 + BC−x
)(
1− 1
3
exp
(
−
(
x− E
4
)2))
for males
(3.17)
The relevant parameters are given in Table 3.3. The function wx (for males)
is plotted in Fig. 3.3.
Table 3.3: Parameters of the Rickayzen - Walsh model
Parameter Females Males
A 0.0017 0.0017
B 1.0934 1.1063
C 103.6000 93.5111
D 0.9567 0.6591
E n.a. 70.3002
40 60 80 100
0.0
0.1
0.2
0.3
0.4
0.5
age
pr
ob
.
 
o
f L
TC
 c
la
im
Figure 3.3: Function wx (i.e. probability of entering the LTC state, as a
function of the attained age x) - Males
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Figure 3.4: Functions qaax and qix (i.e. mortality of healthy lives and LTC
lives, as functions of the attained age x) - Males
An additive extra-mortality model has been assumed to represent the
mortality of disabled people. As suggested by Rickayzen and Walsh (2002),
we have adopted the following formula:
qi
(k)
x = q
[standard]
x +∆(x, α, k) (3.18)
with:
∆(x, α, k) =
α
1 + 1.150−x
max{k − 5, 0}
5
(3.19)
where:
• parameter k expresses the LTC severity category, according to the
OPCS scale (see Martin and Elliot (1992)); in particular:
. 0 ≤ k ≤ 5 denotes less severe LTC states, with no impact on
mortality;
. 6 ≤ k ≤ 10 denotes more severe LTC states, implying an extra-
mortality;
in the following calculations, we have assumed k = 8; hence, qix = qi
(8)
x
for all x;
• according to Rickayzen (2007), we have set α = 0.10, as we have as-
sumed q[standard] = qaax (that is, the mortality of insured healthy people)
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From the previous assumptions, it follows:
∆(x, 0.10, 8) =
0.06
1 + 1.150−x
(3.20)
The age-patterns of mortality for healthy people (i.e. the function qaax )
and for disabled people (i.e. the function qix) are plotted in Fig. 3.4. The
underlying assumptions are given by the Heligman-Pollard law (see Eq. (3.16)
and Table 3.1) and the additive extra-mortality model (see Eqs. (3.18) and
(3.20)).
In all the numerical calculations in Sect. 4 we have assumed the interest
rate 0.02, and hence v = 1.02−1; the biometric assumptions refer to males.
4 Premiums
We consider the following LTCI products:
• Product P1: stand-alone LTC cover;
• Product P2: LTC acceleration benefit in a whole-life assurance;
• Product P3: LTC insurance package, including a deferred life annuity
and a death benefit; in particular:
. Product P3a: Package a (fixed death benefit);
. Product P3b: Package b (decreasing death benefit);
• Product P4: enhanced pension.
According to the equivalence principle, the single premiums are given by
the actuarial values of the benefits.
4.1 Product P1: LTCI as a stand-alone cover
According to the notation adopted in Sect. 3.3, the single premium, for an
annual benefit b, is given by:
Π [P1]x = b a
ai
x (4.1)
and the annual level premiums by:
P [P1]x =
Π
[P1]
x
a¨aax
(4.2a)
P
[P1]
x:re =
Π
[P1]
x
a¨aax:re
(4.2b)
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in the case of non-temporary or temporary premiums respectively. Some
numerical examples are shown in Table 4.1.
Table 4.1: Product P1 (Stand-alone); Single premium Π [P1]x and annual level
premium P [P1]x:re ; b = 100
Age x Single premium Annual level premiums
x+ r = 65 x+ r = 70 x+ r = 75
40 480.4308 26.77075 24.31464 22.83546
50 513.5436 43.53108 36.24584 32.41563
60 516.4653 113.69362 64.93099 49.83906
70 473.7323 −− −− 109.89082
4.2 Product P2: LTCI as an acceleration benefit
Refer to a whole life assurance with sum assured C. The acceleration benefit
consists in a temporary LTC annuity with annual benefit C/s. The single
premium, Π [P2(s)]x , of the whole life assurance with LTC acceleration benefit
is given by:
Π [P2(s)]x = C
+∞∑
j=1
j−1paax q
a
x+j−1 v
j
+ C
+∞∑
j=1
j−1paax p
ai
x+j−1 v
j
[1
s
a¨ix+j:se +
s−1∑
h=1
(
1− h
s
)
h−1pix+j q
i
x+j+h−1 v
h
]
(4.3)
Conversely, the single premium for a (standard) whole life assurance is
given by:
Π [WLA]x = C
+∞∑
j=1
(
j−1paax q
a
x+j−1 + j−1p
ai
x q
i
x+j−1
)
vj (4.4)
Table 4.2 provides some examples. We note that, for any given age x
at policy issue, the higher is s the lower is the single premium because of
spreading the benefit over a longer period from the disability inception. In
particular, if s = 1 then the whole amount C is paid either at the time of
entering the LTC state or at the time of death. We also note that, assuming
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a zero interest rate, the single premium would be equal to C (whatever the
value of s) as the payment of the benefit is sure, only the time and the cause
of payment being random.
Table 4.2: Product P2 (Whole life assurance with LTC acceleration benefit);
Single premiums Π [WLA]x and Π [P2(s)]x ; C = 1000
Age x Whole life Whole life with acceleration benefitno accel. s = 1 s = 2 s = 3 s = 4 s = 5
40 471.5191 565.7242 561.1957 556.9116 552.8608 549.0326
50 560.2152 660.9139 655.7011 650.7873 646.1581 641.7995
60 654.6069 755.8798 750.0631 744.6104 739.5027 734.7218
4.3 Product P3: LTCI in life insurance package
Package (a) provides the following benefits (see also Sect. 2.2):
• a life annuity with annual benefit b′, deferred n years, while the indi-
vidual is healthy;
• an LTC annuity with annual benefit b′′;
• a death benefit C.
Table 4.3: Product P3a (Package a); Single premium Π [P3a(x+n)]x ; C = 1000,
b′ = 50, b′′ = 150
Age x x+ n = 75 x+ n = 80 x+ n = 85
40 1 007.413 970.5772 955.9357
50 1 146.305 1 098.1236 1 078.9723
60 1 275.446 1 206.1263 1 178.5728
70 1 409.858 1 285.7893 1 236.4738
The single premium, Π [P3a(x+n)]x , is given by:
Π [P3a(x+n)]x = b
′
n|a¨aax + b
′′ aaix + C
+∞∑
j=1
(
j−1paax q
a
x+j−1 + j−1p
ai
x q
i
x+j−1
)
vj (4.5)
Some numerical examples are provided in Table 4.3.
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Package (b) includes the following benefits (see also Sect. 2.2):
• a life annuity with annual benefit b′, deferred n years, while the indi-
vidual is healthy;
• an LTC annuity with annual benefit b′′;
• a death benefit max{C − (z′b′ + z′′b′′), 0}, where
z′ = number of annual payments b′;
z′′ = number of annual payments b′′.
The single premium is given by the following expression:
Π [P3b(x+n)]x = b
′
n|a¨aax + b
′′ aaix +Π
[DB3b]
x (4.6)
where the quantity Π [DB3b]x denotes the actuarial value of the death benefit.
This quantity can be split into four terms, according to possible individual
stories:
Π [DB3b]x = Π
(1)
x +Π
(2)
x +Π
(3)
x +Π
(4)
x (4.7)
The four terms refer to the following mutually-exclusive stories.
(1) Death in healthy state before time n
Π(1)x = C
n∑
j=1
j−1paax q
aa
x+j−1 v
j (4.8)
In this case, we have: z′ = z′′ = 0.
(2) Death in healthy state after time n
Π(2)x =
+∞∑
j=n+1
j−1paax q
aa
x+j−1 max{C − (j − n) b′, 0} vj (4.9)
Then: z′ = j − n, z′′ = 0.
(3) Death in LTC state, entered before time n
Π(3)x =
n∑
j=1
j−1paax q
ai
x+j−1C v
j
︸ ︷︷ ︸
death in the 1st LTC year ⇒ no LTC benefit paid
+
n∑
j=1
j−1paax p
ai
x+j−1 v
j
[ +∞∑
h=1
h−1pix+j q
i
x+j+h−1 max{C − h b′′, 0} vh
]
︸ ︷︷ ︸
death in the 2nd or following LTC year ⇒ LTC benefits paid
(4.10)
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In this case: z′ = 0, z′′ = h
(4) Death in LTC state, entered after time n
Π(4)x = np
aa
x v
n
[
+∞∑
j=1
j−1paax+n q
ai
x+n+j−1 max{C − j b′, 0} vj︸ ︷︷ ︸
death in the 1st LTC year ⇒ no LTC benefit paid
+
+∞∑
j=1
j−1paax+n p
ai
x+n+j−1 v
j
[ +∞∑
h=1
h−1pix+n+j q
i
x+n+j+h−1 max{C − j b′ + h b′′), 0} vh
]
︸ ︷︷ ︸
death in the 2nd or following LTC year ⇒ LTC benefits paid
]
(4.11)
In this case, we have: z′ = j, z′′ = h
Some numerical examples are provided in Table 4.4. We note that, for
any age x and any deferment n, we find Π [P3b(x+n)]x < Π [P3a(x+n)]x because of
the different definition of the death benefit.
Table 4.4: Product 3b (Package b); Single premium Π [P3b(x+n)]x ; C = 1000,
b′ = 50, b′′ = 150
Age x x+ n = 75 x+ n = 80 x+ n = 85
40 713.8557 698.9712 694.7115
50 804.2394 784.7703 779.1985
60 883.1407 855.1300 847.1139
70 952.4602 902.3264 887.9789
4.4 Product 4: the enhanced pension
The single premium for a standard pension with annual benefit b is given by:
Π [SP(b)]x = b
+∞∑
j=1
jp
a
x v
j = b
+∞∑
j=1
(jp
aa
x + jp
ai
x ) v
j = b (aaax + a
ai
x ) (4.12)
The single premium for a pension with annual benefits b′, b′′, respectively
paid if the annuitant is either healthy or in the LTC state, is given by:
Π [P4(b
′,b′′)]
x = b
′ aaax + b
′′ aaix (4.13)
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In the case of an enhanced pension, we must have:
Π [P4(b
′,b′′)]
x = Π
[SP(b)]
x (4.14)
and then:
b′ aaax + b
′′ aaix = b (a
aa
x + a
ai
x ) (4.15)
From Eq. (4.15), given b, b′′ we can calculate the reduced pension b′. Con-
versely, given b, b′ we can find the uplifted pension b′′. Some numerical ex-
amples are given in Table 4.5.
Table 4.5: Product P4 (Enhanced pension); reduced benefit b′, in order to
obtain a given LTC benefit b′′ (b = 100)
Age x Π [P4(b
′,b′′)]
x = Π
[SP(b)]
x b′′ = 150 b′′ = 200 b′′ = 250
60 1 761.478 79.259 58.517 37.776
65 1 522.646 75.824 51.649 27.473
70 1 278.444 70.565 41.130 11.695
5 Sensitivity analysis
In this Section we refer to the four LTCI products addressed in Sect. 4, and
assess the sensitivity of the single premiums with respect to the assumptions
on the probability of disablement and the extra-mortality.
Let Π [PX]x (δ, λ) denote the single premium of the LTCI product PX, with
X = 1, 2, 3, according to the following assumptions:
• probability of entering the LTC state (i.e. probability of disablement)
w¯x(δ), defined as follows:
w¯x(δ) = δ wx (5.1)
where wx is given by Eq. (3.17), with parameters as specified in Table
3.3 for males;
• extra-mortality of people in the LTC state, defined as follows
∆¯(x;λ) = λ∆(x, 0.10, 8) =
λ 0.06
1 + 1.150−x
(5.2)
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(see Eq. (3.20)); it follows that the mortality of disabled people is given
by:
qix(λ) = q
aa
x + ∆¯(x;λ) (5.3)
we note that λ = 0 means absence of extra-mortality.
As regards the product P4, let b′(δ, λ) denote the amount of the reduced
pension which meets a given uplifted pension b′′ (for a given value of b),
according to the assumptions expressed by δ and λ.
To ease the comparisons, we define for the LTCI products P1, P2 and P3
the “normalized” single premium, that is the ratio:
ρ[PX]x (δ, λ) =
Π
[PX]
x (δ, λ)
Π
[PX]
x (1, 1)
(5.4)
whereas for the product P4, with given b and b′′, we define the ratio:
ρ[P4]x (δ, λ) =
b′(1, 1)
b′(δ, λ)
(5.5)
For all the products, we first perform a “marginal” analysis, by analyzing
the behavior of the functions:
Π [PX]x (δ, 1) for X = 1, 2, 3; b
′(δ, 1); ρ[PX]x (δ, 1) for X = 1, 2, 3, 4
to assess the sensitivity with respect to the disablement assumption (Sect. 5.1),
and the functions:
Π [PX]x (1, λ) for X = 1, 2, 3; b
′(1, λ); ρ[PX]x (1, λ) for X = 1, 2, 3, 4
to assess the sensitivity with respect to the mortality assumption (Sect. 5.2).
Some results of a “joint” sensitivity analysis are finally presented (Sect. 5.3).
5.1 Disablement assumption
Some results of sensitivity analysis with respect to disablement assumption
are shown in Tables 5.1 to 5.4, in terms of single premiums, normalized single
premiums and reduced benefit in the enhanced pension.
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Table 5.1: Product P1 (Stand-alone); x = 50, b = 100
δ Π
[P1]
50 (δ, 1) ρ
[P1]
50 (δ, 1)
0.0 0.00000 0.0000000
0.1 97.44457 0.1897494
0.2 176.07799 0.3428686
0.3 241.25240 0.4697798
0.4 296.47515 0.5773125
0.5 344.12555 0.6700999
0.6 385.86840 0.7513839
0.7 422.90118 0.8234961
0.8 456.10675 0.8881558
0.9 486.15044 0.9466585
1.0 513.54361 1.0000000
1.1 538.68628 1.0489592
1.2 561.89632 1.0941550
1.3 583.42997 1.1360865
1.4 603.49644 1.1751610
1.5 622.26854 1.2117151
1.6 639.89052 1.2460296
1.7 656.48397 1.2783412
1.8 672.15229 1.3088514
1.9 686.98406 1.3377327
2.0 701.05581 1.3651339
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Table 5.2: Product P2 (Acceleration benefit); x = 50, C = 1000
δ Π
[P2(1)]
50 (δ, 1) ρ
[P2(1)]
50 (δ, 1) Π
[P2(5)]
50 (δ, 1) ρ
[P2(5)]
50 (δ, 1)
0.0 492.1453 0.7446436 492.1453 0.7668209
0.1 522.4302 0.7904664 517.9195 0.8069802
0.2 547.3508 0.8281727 539.5114 0.8406230
0.3 568.3981 0.8600184 558.0108 0.8694472
0.4 586.5416 0.8874705 574.1426 0.8945825
0.5 602.4415 0.9115280 588.4118 0.9168156
0.6 616.5641 0.9328964 601.1825 0.9367139
0.7 629.2483 0.9520882 612.7241 0.9546971
0.8 640.7467 0.9694859 623.2411 0.9710837
0.9 651.2520 0.9853810 632.8914 0.9861200
1.0 660.9139 1.0000000 641.7995 1.0000000
1.1 669.8509 1.0135223 650.0652 1.0128789
1.2 678.1584 1.0260919 657.7693 1.0248828
1.3 685.9139 1.0378264 664.9783 1.0361152
1.4 693.1814 1.0488226 671.7475 1.0466625
1.5 700.0145 1.0591615 678.1234 1.0565969
1.6 706.4581 1.0689111 684.1455 1.0659801
1.7 712.5507 1.0781294 689.8475 1.0748645
1.8 718.3251 1.0868664 695.2586 1.0832956
1.9 723.8097 1.0951649 700.4040 1.0913127
2.0 729.0293 1.1030626 705.3059 1.0989504
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Table 5.3: Products P3a, P3b (Insurance packages); x = 50, C = 1000,
b′ = 50, b′′ = 150
δ Π
[P3a(80)]
50 (δ, 1) ρ
[P3a(80)]
50 (δ, 1) Π
[P3b(80)]
50 (δ, 1) ρ
[P3b(80)]
50 (δ, 1)
0.0 700.5211 0.6379255 524.3054 0.6681005
0.1 762.7792 0.6946205 564.2116 0.7189513
0.2 816.5343 0.7435723 598.8261 0.7630591
0.3 863.9507 0.7867518 629.5434 0.8022009
0.4 906.4564 0.8254594 657.2615 0.8375209
0.5 945.0332 0.8605891 682.5844 0.8697888
0.6 980.3808 0.8927781 705.9351 0.8995436
0.7 1 013.0142 0.9224956 727.6214 0.9271776
0.8 1 043.3239 0.9500969 747.8754 0.9529864
0.9 1 071.6132 0.9758584 766.8772 0.9771996
1.0 1 098.1236 1.0000000 784.7703 1.0000000
1.1 1 123.0514 1.0227003 801.6718 1.0215369
1.2 1 146.5586 1.0441071 817.6790 1.0419342
1.3 1 168.7817 1.0643443 832.8740 1.0612966
1.4 1 189.8365 1.0835178 847.3271 1.0797136
1.5 1 209.8231 1.1017185 861.0993 1.0972629
1.6 1 228.8288 1.1190259 874.2436 1.1140122
1.7 1 246.9299 1.1355096 886.8072 1.1300214
1.8 1 264.1943 1.1512313 898.8317 1.1453438
1.9 1 280.6825 1.1662462 910.3545 1.1600268
2.0 1 296.4487 1.1806036 921.4091 1.1741132
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Table 5.4: Product P4 (Enhanced pension); x = 65, b = 100, b′′ = 150
δ b′(δ, 1) ρ[P4]x (δ, 1)
0.0 100.00000 0.7582433
0.1 96.96404 0.7819840
0.2 94.13166 0.8055136
0.3 91.47026 0.8289506
0.4 88.95221 0.8524165
0.5 86.55461 0.8760288
0.6 84.25873 0.8998988
0.7 82.04926 0.9241317
0.8 79.91365 0.9488283
0.9 77.84153 0.9740858
1.0 75.82433 1.0000000
1.1 73.85486 1.0266668
1.2 71.92708 1.0541833
1.3 70.03587 1.0826500
1.4 68.17685 1.1121713
1.5 66.34626 1.1428576
1.6 64.54086 1.1748267
1.7 62.75783 1.2082052
1.8 60.99468 1.2431301
1.9 59.24927 1.2797513
2.0 57.51967 1.3182330
From the numerical results, we immediately recognize the stand-alone
LTCI product, i.e. product P1, as the one with the highest sensitivity with
respect to the disablement assumption. This (rather intuitive) result is also
evident in graphical terms, as shown by Fig. 5.1. We note, in particular,
the dramatic impact of a possible underestimation of the probability of dis-
ablement, expressed by δ < 1 (even excluding non-realistic underestimations,
which could be represented by, say, 0 ≤ δ < 0.5).
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Figure 5.1: Disablement assumption - Sensitivity analysis
5.2 Extra-mortality assumption
Some results of sensitivity analysis with respect to extra-mortality assump-
tion are shown in Tables 5.5 to 5.8, in terms of single premiums, normalized
single premiums and reduced benefit in the enhanced pension.
The numerical results show that the stand-alone LTCI product, i.e. prod-
uct P1, is the one with the highest sensitivity also with respect to the extra-
mortality assumption. See Fig. 5.2. We note that a safety loading could be
included in the premium by underestimating the extra-mortality of disabled
people.
Conversely, the extra-mortality assumption has no impact on the pre-
mium of the whole life assurance with acceleration benefit if s = 1: indeed,
in this case the whole death benefit is paid upon the LTC claim. Further, a
very low impact affects the case s = 5.
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Table 5.5: Product P1 (Stand-alone); x = 50, b = 100
λ Π
[P1]
50 (1, λ) ρ
[P1]
50 (1, λ)
0.0 855.7094 1.6662838
0.1 806.6737 1.5707987
0.2 761.9567 1.4837234
0.3 721.0856 1.4041370
0.4 683.6467 1.3312339
0.5 649.2769 1.2643073
0.6 617.6576 1.2027364
0.7 588.5080 1.1459748
0.8 561.5807 1.0935405
0.9 536.6571 1.0450079
1.0 513.5436 1.0000000
1.1 492.0686 0.9581828
1.2 472.0797 0.9192592
1.3 453.4411 0.8829652
1.4 436.0319 0.8490650
1.5 419.7439 0.8173482
1.6 404.4804 0.7876263
1.7 390.1547 0.7597305
1.8 376.6889 0.7335090
1.9 364.0128 0.7088255
2.0 352.0634 0.6855570
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Table 5.6: Product P2 (Acceleration benefit); x = 50, C = 1000
λ Π
[P2(1)]
50 (1, λ) ρ
[P2(1)]
50 (1, λ) Π
[P2(5)]
50 (1, λ) ρ
[P2(5)]
50 (1, λ)
0.0 660.9139 1 640.3371 0.9977214
0.1 660.9139 1 640.4879 0.9979563
0.2 660.9139 1 640.6376 0.9981896
0.3 660.9139 1 640.7863 0.9984213
0.4 660.9139 1 640.9341 0.9986515
0.5 660.9139 1 641.0808 0.9988801
0.6 660.9139 1 641.2265 0.9991071
0.7 660.9139 1 641.3712 0.9993326
0.8 660.9139 1 641.5150 0.9995566
0.9 660.9139 1 641.6577 0.9997791
1.0 660.9139 1 641.7995 1.0000000
1.1 660.9139 1 641.9404 1.0002194
1.2 660.9139 1 642.0802 1.0004374
1.3 660.9139 1 642.2191 1.0006538
1.4 660.9139 1 642.3571 1.0008688
1.5 660.9139 1 642.4941 1.0010822
1.6 660.9139 1 642.6302 1.0012943
1.7 660.9139 1 642.7653 1.0015048
1.8 660.9139 1 642.8995 1.0017140
1.9 660.9139 1 643.0328 1.0019216
2.0 660.9139 1 643.1652 1.0021279
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Table 5.7: Products P3a, P3b (Insurance packages); x = 50, C = 1000,
b′ = 50, b′′ = 150
λ Π
[P3a(80)]
50 (1, λ) ρ
[P3a(80)]
50 (1, λ) Π
[P3b(80)]
50 (1, λ) ρ
[P3b(80)]
50 (1, λ)
0.0 1 373.1426 1.2504444 1 030.1514 1.3126789
0.1 1 333.7360 1.2145591 992.0364 1.2641106
0.2 1 297.7979 1.1818323 957.9426 1.2206663
0.3 1 264.9490 1.1519186 927.4057 1.1817544
0.4 1 234.8573 1.1245157 900.0200 1.1468579
0.5 1 207.2314 1.0993584 875.4306 1.1155246
0.6 1 181.8156 1.0762136 853.3264 1.0873583
0.7 1 158.3843 1.0548760 833.4345 1.0620108
0.8 1 136.7389 1.0351648 815.5147 1.0391763
0.9 1 116.7039 1.0169200 799.3555 1.0185853
1.0 1 098.1236 1.0000000 784.7703 1.0000000
1.1 1 080.8603 0.9842793 771.5943 0.9832104
1.2 1 064.7915 0.9696463 759.6816 0.9680305
1.3 1 049.8081 0.9560017 748.9029 0.9542957
1.4 1 035.8128 0.9432570 739.1434 0.9418596
1.5 1 022.7189 0.9313331 730.3010 0.9305921
1.6 1 010.4485 0.9201591 722.2849 0.9203775
1.7 998.9319 0.9096716 715.0140 0.9111125
1.8 988.1065 0.8998136 708.4160 0.9027050
1.9 977.9161 0.8905337 702.4263 0.8950725
2.0 968.3098 0.8817858 696.9867 0.8881411
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Table 5.8: Product P4 (Enhanced pension); x = 65, b = 100, b′′ = 150
λ b′(1, λ) ρ[P4]x (1, λ)
0.0 62.34898 1.2161277
0.1 64.17119 1.1815946
0.2 65.86125 1.1512738
0.3 67.43103 1.1244723
0.4 68.89119 1.1006390
0.5 70.25128 1.0793302
0.6 71.51992 1.0601847
0.7 72.70488 1.0429056
0.8 73.81315 1.0272469
0.9 74.85106 1.0130027
1.0 75.82433 1.0000000
1.1 76.73813 0.9880920
1.2 77.59716 0.9771534
1.3 78.40567 0.9670771
1.4 79.16755 0.9577704
1.5 79.88630 0.9491531
1.6 80.56513 0.9411556
1.7 81.20698 0.9337169
1.8 81.81451 0.9267834
1.9 82.39015 0.9203081
2.0 82.93615 0.9142494
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Figure 5.2: Extra-mortality assumption - Sensitivity analysis
5.3 Joint sensitivity analysis
A joint sensitivity analysis can produce various results of practical interest.
It can be performed looking, in particular, at the surface which represents
the behavior of the function
z = Π [PX]x (δ, λ) (5.6)
For example, Fig. 5.3 shows the behavior of the function z = Π [P3a(80)]50 (δ, λ).
For brevity, we only focus on sensitivity analysis aiming at finding, for
the generic product PX and a given age x, the set of pairs (δ, λ) such that:
ρ[PX]x (δ, λ) = ρ
[PX]
x (1, 1) = 1 (5.7)
Eq. (5.7) implies for products P1, P2, P3:
Π [PX]x (δ, λ) = Π
[PX]
x (1, 1) (5.8)
We note that Eq. (5.8) represents an “isopremium” line: actually, all the pairs
(δ, λ) which fulfill this equation lead to the same single premium.
For product P4, Eq. (5.7) implies:
b′(δ, λ) = b′(1, 1) (5.9)
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z
Figure 5.3: Product P3a(80); X = δ (disablement), Y = λ (extra-mortality),
Z = Π(premium)
Hence, the graphical representation of Eqs. (5.7) to (5.9) provides an
insight into the possible offset between, for example, an overestimation of
the extra-mortality and an overestimation of the probability of entering the
LTC state.
The isopremium curves plotted in Fig. 5.4 show this possibility with ref-
erence to products P1 and P3a(80).
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Figure 5.4: Offset effect: isopremium lines
6 Concluding remarks
Combined LTCI products mainly aim at reducing the relative weight of the
“risk” component by introducing a “saving” component into the product, or
by adding the LTC benefits to an insurance product with an important saving
component.
In more general terms, in the area of health insurance a combined product
can result profitable to the insurance company even if one of its components
is not profitable, and, further, it can be less risky than one of its components,
being in particular less exposed to the impact of uncertainty risk related to
the choice of technical bases.
Numerical examples show that, for example, the LTC stand-alone cover
is much riskier than all the LTC combined products we have considered.
From the client’s perspective, purchasing a combined product can be less
expensive than separately purchasing all the single components, in particular
thanks to a reduction of acquisition costs charged to the policyholder, but
also thanks to a possible lower total safety loading.
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